Table 1 |
||||
|
Dietary intake after 1 year of treatment with orlistat |
||||
|
All participants (n = 63) |
High attendance group (n = 31) |
Low attendance group (n = 32) |
P* |
|
|
|
||||
|
Energy intake (kJ) |
||||
|
1 year |
9229 ± 2304† |
8747 ± 2033 |
9696 ± 2483 |
|
|
Change‡ |
178 [-366, 722] § |
-57 ± 1618 |
406 ± 2661 |
0.409 |
|
Energy density (kJ/g) |
||||
|
1 year |
5.3 ± 1.5 |
4.7 ± 1.2 |
5.9 ± 1.5 |
|
|
Change |
0.5 [0.2, 0.7] |
0.1 ± 0.9 |
0.8 ± 1.0 |
0.008 |
|
Fat (E%) |
||||
|
1 year |
29.7 ± 7.3 |
27.3 ± 6.5 |
32.0 ± 7.4 |
|
|
Change |
1.7 [-0.2, 3.6] |
0.2 ± 6.6 |
3.2 ± 8.5 |
0.117 |
|
Saturated fat (E%) |
||||
|
1 year |
10.1 ± 3.7 |
8.6 ± 2.4 |
11.5 ± 4.1 |
|
|
Change |
1.2 [0.4, 2.0] |
0.7 ± 1.7 |
1.7 ± 4.2 |
0.201 |
|
Monounsaturated fat (E%) |
||||
|
1 year |
10.1 ± 3.7 |
8.6 ± 2.4 |
11.5 ± 4.1 |
|
|
Change |
-1.3 [-2.2, -0.3] |
-2.6 ± 2.9 |
0 ± 4.5 |
0.009 |
|
Polyunsaturated fat (E%) |
||||
|
1 year |
5.4 ± 1.7 |
5.3 ± 2.1 |
5.4 ± 1.3 |
|
|
Change |
0 [-0.5, 0.5] |
-0.3 ± 2.2 |
0.3 ± 1.4 |
0.169 |
|
Protein (E%) |
||||
|
1 year |
17.4 ± 2.7 |
18.3 ± 2.5 |
16.5 ± 2.6 |
|
|
Change |
0 [-0.6, 0.8] |
0.8 ± 3.3 |
0.3 ± 1.4 |
0.051 |
|
Carbohydrate (E%) |
||||
|
1 year |
47.7 ± 6.5 |
48.7 ± 6.3 |
46.7 ± 6.5 |
|
|
Change |
-1.9 [-3.7, -0.2] |
-0.4 ± 5.9 |
-3.4 ± 1.4 |
0.089 |
|
Fiber (g/MJ) |
||||
|
1 year |
3.9 ± 1.4 |
4.3 ± 1.5 |
3.5 ± 1.2 |
|
|
Change |
-0.3 [-0.6, -0.1] |
-0.1 ± 1.2 |
-0.5 ± 0.8 |
0.143 |
|
|
||||
|
* Comparison of changes between the high and low attendance group (unpaired t-test). The subjects in the high attendance group attended more group sessions than the mean which was 9.34 sessions and the subjects in the low attendance group attended = 9.34 sessions. † Mean ± SD ‡ Changes are calculated as the difference between 1 year and the start of orlistat. § Mean; 95% CI in brackets. |
||||
|
Svendsen and Tonstad Nutrition Journal 2011 10:21 doi:10.1186/1475-2891-10-21 |
||||